 |
Corporate News
18-Mar-25
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals allots 1,700 equity shares under ESOS
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has allotted 1,700 equity shares under ESOS on 18 March 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,75,508 equity shares of Re. 1 each to 15,56,77,208 equity shares of Re. 1 each.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals consolidated net profit rises 19.05% in the September 2025 quarter
(
Results
-
Announcements
12-Nov-25
07:41
)
|
|
|
J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets
(
Corporate News
-
26-Jun-25
18:33
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 43.97% in the March 2024 quarter
(
Results
-
Announcements
18-May-24
09:31
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.92% in the September 2024 quarter
(
Results
-
Announcements
07-Nov-24
07:33
)
|
|
|
J B Chemicals & Pharmaceuticals to pay interim dividend
(
Market Beat
-
Reports
05-Feb-26
20:23
)
|
|
|
Volumes spurt at Galaxy Surfactants Ltd counter
(
Hot Pursuit
-
27-Mar-25
11:00
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends final dividend
(
Corporate News
-
18-May-24
09:31
)
|
|
|
J B Chemicals & Pharmaceuticals Ltd gains for third consecutive session
(
Hot Pursuit
-
05-Apr-24
13:05
)
|
|
|
J B Chemicals & Pharmaceuticals completes acquisition of portfolio of brands from Dr Reddy's
(
Corporate News
-
21-Jul-22
19:03
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends Interim Dividend
(
Corporate News
-
09-Feb-23
10:49
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 92.58% in the June 2020 quarter
(
Results
-
Announcements
15-Sep-20
08:45
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|